Drs. Bossi, Wallis on the Right Patients for Radiotherapy When Presenting With De Novo mCSPC

Alberto Bossi, MD, Gustave Roussy Cancer Institute, and Christopher Wallis, MD, PhD, University of Toronto, conclude their discussion with a detailed breakdown of who the right patients for radiotherapy may be when presenting with de novo mCSPC.

In the first two parts of this video series, Drs. Bossi and Wallis detailed the design and results of the PEACE-1 as well as commented on whether all patients with de novo mCSPC experience synergistic effects on treatment with abiraterone plus radiotherapy.

View their previous discussions on Prostate Irradiation in Men With De Novo, Low-Volume mCSPC and the Synergistic Effects of Abiraterone, Radiotherapy for De Novo mCSPC.